JO3525B1 - Treatment of metastatic stage prostate cancer with degarelix - Google Patents

Treatment of metastatic stage prostate cancer with degarelix

Info

Publication number
JO3525B1
JO3525B1 JOP/2009/0062A JOP20090062A JO3525B1 JO 3525 B1 JO3525 B1 JO 3525B1 JO P20090062 A JOP20090062 A JO P20090062A JO 3525 B1 JO3525 B1 JO 3525B1
Authority
JO
Jordan
Prior art keywords
degarelix
treatment
prostate cancer
stage prostate
metastatic stage
Prior art date
Application number
JOP/2009/0062A
Other languages
Arabic (ar)
Inventor
Persson Bo-Eric
Original Assignee
Ferring Int Center Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Int Center Sa filed Critical Ferring Int Center Sa
Application granted granted Critical
Publication of JO3525B1 publication Critical patent/JO3525B1/en

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Compositions comprising degarelix for the treatment of metastatic stage prostate cancer in a subject are provided.
JOP/2009/0062A 2008-02-11 2009-02-09 Treatment of metastatic stage prostate cancer with degarelix JO3525B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2774108P 2008-02-11 2008-02-11
EP08250703 2008-02-29

Publications (1)

Publication Number Publication Date
JO3525B1 true JO3525B1 (en) 2020-07-05

Family

ID=69095472

Family Applications (1)

Application Number Title Priority Date Filing Date
JOP/2009/0062A JO3525B1 (en) 2008-02-11 2009-02-09 Treatment of metastatic stage prostate cancer with degarelix

Country Status (3)

Country Link
JP (1) JP7104003B2 (en)
HK (1) HK1258957A1 (en)
JO (1) JO3525B1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JOP20090061B1 (en) * 2008-02-11 2021-08-17 Ferring Int Center Sa METHODS OF TREATING PROSTATE CANCER WITH GnRH ANTAGONIST

Also Published As

Publication number Publication date
JP2019218360A (en) 2019-12-26
HK1258957A1 (en) 2019-11-22
JP7104003B2 (en) 2022-07-20

Similar Documents

Publication Publication Date Title
MX2010008817A (en) Treatment of metastatic stage prostate cancer with degarelix.
IN2012DN02046A (en)
SI2358697T1 (en) Isoindoline compounds for use in the treatment of cancer.
EP2197533A4 (en) Prostate cancer ablation
JO2788B1 (en) Amidophenoxyindazoles useful as inhibitors of c-met
ZA201102362B (en) Molecular markers in prostate cancer
EP2135600A4 (en) Targeting agent for cancer cell or cancer-associated fibroblast
EP2200431A4 (en) Novel compositions and methods for cancer treatment
MX2010000465A (en) Methods and compositions for the treatment of cancer, tumors, and tumor-related disorders.
EP2310006A4 (en) Treating cancer
MX2011011431A (en) Composition for the treatment of prostate cancer.
MY146112A (en) Long-term feed - cancer patient
IL186980A0 (en) Characterizing prostate cancer
EP2300040A4 (en) Methods and compositions for prostate cancer immunotherapy
GB0804496D0 (en) Treating cancer
EP2374463A4 (en) Composition for improving radiotherapy for cancer
EP2137213A4 (en) Methods and compositions for treating prostate cancer
JO3525B1 (en) Treatment of metastatic stage prostate cancer with degarelix
GB0809046D0 (en) Cancer treatment
WO2009097095A9 (en) Methods for treating hematopoietic malignancies
WO2010002454A3 (en) Therapeutic combinations for use in neoplasia
AU323022S (en) Birdcage roof
GB0818566D0 (en) Improvements in the chemotherapy of cancer
GB0809730D0 (en) Improvements in the chemotherapy of cancer
JO3550B1 (en) Composition for the Treatment of Prostate Cancer